Literature DB >> 17252594

Clinical significance of MMP-2 and MMP-9 in patients with oral cancer.

Beena P Patel1, Shakuntala V Shah, Shilin N Shukla, Pankaj M Shah, Prabhudas S Patel.   

Abstract

BACKGROUND: Factors that represent the potential for invasion and metastasis, such as matrix metalloproteinases (MMPs), could predict prognosis of cancer. Therefore, the authors studied plasma and tissue levels of MMP-2 and MMP-9 in oral cancer, the leading malignancy in India.
METHODS: Enzyme-linked immunosorbent assay and gelatin zymography were used for the MMP analysis from plasma and tissue samples, respectively.
RESULTS: Latent, active, and total forms and activation ratio of MMP-2 and MMP-9 were significantly elevated in malignant tissues as compared with adjacent normal tissues. Activation of MMP-2 was higher than MMP-9 in malignant tissues. Activation ratio was significantly higher in malignant tissues of the patients with lymph node metastasis as compared with those without lymph node metastasis (p = .005). Plasma MMP-9 levels were significantly lower in responders as compared with pretreatment levels (p = .002).
CONCLUSION: The data indicate that MMP-2 and MMP-9 can be useful to identify metastatic phenotype as well as for treatment monitoring in oral cancer. (c) 2007 Wiley Periodicals, Inc. Head Neck, 2007.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17252594     DOI: 10.1002/hed.20561

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  39 in total

1.  Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.

Authors:  Noha A Ghallab; Olfat G Shaker
Journal:  Clin Oral Investig       Date:  2016-05-10       Impact factor: 3.573

2.  Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.

Authors:  Kamdeo K Pramanik; Siddavaram Nagini; Abhay K Singh; Prajna Mishra; Tanushree Kashyap; Nidhi Nath; Manzar Alam; Ajay Rana; Rajakishore Mishra
Journal:  Cell Oncol (Dordr)       Date:  2017-11-13       Impact factor: 6.730

3.  Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.

Authors:  Sabrina Daniela Silva; Moulay A Alaoui-Jamali; Michael Hier; Fernando Augusto Soares; Edgard Graner; Luiz Paulo Kowalski
Journal:  Clin Exp Metastasis       Date:  2013-12-15       Impact factor: 5.150

4.  A review on salivary genomics and proteomics biomarkers in oral cancer.

Authors:  Franky D Shah; Rasheedunnisa Begum; Bhairavi N Vajaria; Kinjal R Patel; Jayendra B Patel; Shilin N Shukla; Prabhudas S Patel
Journal:  Indian J Clin Biochem       Date:  2011-08-09

5.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.

Authors:  Xiqiang Liu; Antonia Kolokythas; Jianguang Wang; Hongzhang Huang; Xiaofeng Zhou
Journal:  Curr Cancer Ther Rev       Date:  2010-11-01

6.  Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.

Authors:  Zhenkun Zhu; Xin Xu; Yanke Yu; Martin Graham; Mark E Prince; Thomas E Carey; Duxin Sun
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

7.  Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.

Authors:  Xiao-Han Tang; Kwame Osei-Sarfo; Alison M Urvalek; Tuo Zhang; Theresa Scognamiglio; Lorraine J Gudas
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-03       Impact factor: 11.205

8.  Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma.

Authors:  Zhen Liu; Lixia Li; Zhixiong Yang; Weiren Luo; Xin Li; Huiling Yang; Kaitai Yao; Bin Wu; Weiyi Fang
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

9.  Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis.

Authors:  Pawan Kumar; Arti Yadav; Samip N Patel; Mozaffarul Islam; Quintin Pan; Sofia D Merajver; Theodoros N Teknos
Journal:  Mol Cancer       Date:  2010-08-03       Impact factor: 27.401

10.  Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation.

Authors:  Sophia Bornstein; Ruth White; Stephen Malkoski; Masako Oka; Gangwen Han; Timothy Cleaver; Douglas Reh; Peter Andersen; Neil Gross; Susan Olson; Chuxia Deng; Shi-Long Lu; Xiao-Jing Wang
Journal:  J Clin Invest       Date:  2009-10-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.